oral semaglutide novo FDA approves Rybelsus to treat type 2 diabetes Novo says it's submitted obesity

Weight usually rises later in the day, so morning is best if consistency is your goal but any time works as long as the conditions stay the same each time

Aerobic exercise and metabolic syndrome: the role of sympathetic activity and the redox system

Metabolic drivers of non-alcoholic fatty liver disease

Nine clinical questions were identified, and the experts reviewed the medical literature and gave their current recommendations based on evidence in the medical literature to assist in clinical practice of MASLD and obesity in children [Table 1]

Remote Patient Monitoring for Continuous Care Remote patient monitoring is reshaping how clinicians and patients manage GLP-1 therapy: Continuous glucose monitoring (CGM): CGM devices seamlessly integrate with apps, enabling real-time adjustments to therapy